Ottobock SE & Co KGaA (XETR:OBCK) Share Price

Company Profile

Business description
Ottobock SE & Co KGaA is a medical technology company. It specializes in healthcare products and solutions designed to improve mobility and quality of life for people with disabilities or limited mobility. The company's portfolio includes prosthetics, orthotics, neuro-orthotics, rehabilitation products, wheelchairs, and bionic exoskeletons. The company manages its business activities through the operating segments EMEA (Europe, Middle East and Africa), Americas (North and South America) and APAC (Asia Pacific). The company develops, produces and distributes medical technology products and components in these regions and operates an extensive network of patient care facilities. The majority of revenue is derived from the EMEA segment.
Contact
Max-Nader-Strabe 15
DuderstadtNI37115
DEU
T: +49 55278480
https://corporate.ottobock.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
10,365

Recommended

Wide moat Eli Lilly receives FDA approval for obesity pill.

Karen Andersen, CFA | 02 April 2026

These companies are our favourite choices for investors wanting to boost Aussie equity exposure.

Simonelle Mody | 02 April 2026

OpenAI, Anthropic, and Databricks are expected to go public this year at massive valuations.

Harrison Rolfes | 02 April 2026

Index	Last price	Change	% Change
All Ordinaries	8,774.90	124.80	-1.40%
CAC 40	7,892.33	88.94	-1.11%
DAX 40	22,842.61	456.28	-1.96%
Dow JONES (US)	46,565.74	224.23	0.48%
FTSE 100	10,344.95	19.84	-0.19%
HKSE	25,116.53	177.50	-0.70%
NASDAQ	21,840.95	250.32	1.16%
Nikkei 225	52,463.27	1,276.41	-2.38%
NZX 50 Index	12,902.15	76.28	0.59%
S&P 500	6,575.32	46.80	0.72%
S&P/ASX 200	8,579.50	105.50	-1.21%
SSE Composite Index	3,919.29	29.27	-0.74%